“…In recent studies, many attempts have been made to improve the performance of CαAMPs. These strategies involve re-engineering natural CαAMP sequences by site-directed mutation (Ahmad et al, 2009;Irazazabal et al, 2016;Li et al, 2016;Jiang et al, 2020), fragmentation (Luo et al, 2021) or chemical modification (Zarina and Nanda, 2014;Nayak et al, 2018;Mourtada et al, 2019;Mwangi et al, 2019;Li et al, 2020), computational approaches based on natural templates and statistical analysis (Loose et al, 2006;Nagarajan et al, 2018Nagarajan et al, , 2019, or designing de novo sequences by using simple alkaline vs hydrophobic amino acid combinations (Deslouches et al, 2005(Deslouches et al, , 2013Hu et al, 2011;Lakshmaiah Narayana et al, 2020). However, partly due to the complexity of the structure-activity relationships, which are derived from the sequence diversity of the peptides, progress in CαAMP optimization is still very limited and few CαAMPs have successfully achieved FDA approval (Greber and Dawgul, 2017;Ghosh et al, 2019;Torres et al, 2019).…”